Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-kappaB activation.
about
AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activationNon-EST based prediction of exon skipping and intron retention events using Pfam information.Tumor necrosis factor receptor-associated factors (TRAFs)The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart.Genetic deletion of TNFRII gene enhances the Alzheimer-like pathology in an APP transgenic mouse model via reduction of phosphorylated IκBα.TRAF1: lord without a RING.TNF-receptor-associated factors as targets for drug development.Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis.Phylogenetic Analysis of Brassica rapa MATH-Domain ProteinsAlternative splicing in the NF-kappaB signaling pathway.Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site.Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly.Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling.MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner.Alternative splicing regulation in tumor necrosis factor-mediated inflammation.Molecular cloning and characterization of RBCK2, a splicing variant of a RBCC family protein, RBCK1.Peg3/Pw1 is involved in p53-mediated cell death pathway in brain ischemia/hypoxia.TRAF1 is a TNF inducible regulator of NF-kappaB activation.RED AND FAR-RED INSENSITIVE 2, a RING-domain zinc finger protein, mediates phytochrome-controlled seedling deetiolation responses.TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
P2860
Q24301284-D9AE8BD0-16B6-4C49-9F37-25E976E8C821Q24530809-52B105FE-03A4-4475-86FF-5CF089EBCF09Q28199382-7844B4F1-B9A6-4CBB-BE22-5B0B8C5543F9Q34022068-E309260E-EDAD-43C7-9EA5-F6655EE65E50Q34106250-426A3C05-2DC3-475E-BA0C-29658166AC7CQ34649278-C89DE137-1389-4BB4-A26C-0B971E47AF11Q35143919-A487FDA5-2848-4072-B4F1-E2340210ED70Q36623903-19C7ADFA-13AE-42DC-AB5C-28DDEFE7F18AQ36877053-C7AF42E0-535F-4457-9AFE-FF30DF83C42EQ37057998-D8A8FC92-B052-4ED1-A766-A7EEA3988E06Q39318861-9C1B3FF1-8C8D-4564-B6DB-3FC94865E02FQ40397512-B2C5F571-5F6E-423E-B5F4-F2ABE665B90AQ40739271-63CEFBC6-F005-4696-94FE-989D878B2D05Q43000325-2FE53386-F3E6-4A72-A858-A4057464C0C2Q46630234-C84143E5-82AE-4A1B-887C-136C719FB668Q47150277-591CDC71-C29B-4831-9F5F-DBE4BE8F1710Q47162174-C801DFF3-4411-4507-A8BA-FDECA6F9A037Q48019335-2B089BD2-ABBC-403F-A3B6-FCB9F74E08C2Q48731045-09252373-01C1-431D-959D-867DDDF59A4BQ49169745-09712219-DB47-4EC0-A024-0BCDE35DECBBQ50746266-8B2901C9-12A6-4DE7-AAC5-683544590719Q50792035-6C2E8705-4D4A-44AA-9723-F7A46CD51077
P2860
Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-kappaB activation.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Tumor necrosis factor receptor ...... mediated NF-kappaB activation.
@en
type
label
Tumor necrosis factor receptor ...... mediated NF-kappaB activation.
@en
prefLabel
Tumor necrosis factor receptor ...... mediated NF-kappaB activation.
@en
P2860
P356
P1476
Tumor necrosis factor receptor ...... mediated NF-kappaB activation.
@en
P2093
P2860
P304
P356
10.1074/JBC.273.7.4129
P407
P577
1998-02-01T00:00:00Z